Chemerin, Resistin, and Various Biochemical Markers in the Serum of Individuals Affected by Myocardial Infarction
DOI:
https://doi.org/10.24237/ASJ.03.01.843CKeywords:
Myocardial infarction, chemerin, resistin, myocardial biomarkers, lipid profileAbstract
Myocardial infarction (MI) is a widespread disease that may lead to death. Atherosclerosis is one of the main causes of a heart attack. Due to the narrowing of the arteries, it leads to the aggregation of LDL. As a result of this aggregation, a clot is formed. This clot leads to a complete or partial blockage of these arteries, followed by the death of a section of the heart muscle. Then, ischemic heart disease occurs because the heart’s need for oxygen is greater than the amount it receives. The study aimed to discover the relationship between the MI and alteration of chemerin, resistin and some myocardial biomarkers by evaluating this biomarkers in MI patients and to compare them with those of controls. The parameters which evaluated in study were cardiac enzymes including lactate dehydrogenase (LDH), aspartate aminotransferase (AST), creatine kinase MB (CK-MB), troponin I (TnI) and lipid profile (cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), and very low density lipoprotein (VLDL-C)) in addition to chemerin and resistin.
This study was conducted in Baqubah Teaching Hospital / Diyala Governorate from Jan/2023 until May /2023, Included the collection of samples were collected from patients lying in the cardiac care unit (CCU) who had suffered from myocardial infarction (MI). The study included 60 patients with an average age of (59.31±1.64) years, and the patients were compared with 60 healthy people as a control group, with an average age of (54.86±0.88) years.
The result showed an increase in the levels of chemerin, resistin, TnI, LDH, AST and CK-MB significantly in patients of MI after 24-72hrs of entering attack. The ievels of lipid profile parameters were not changed significantly in patients of MI after admitted to Cardiac Care Unit (CCU) and this may due to receive of Hyperlipidemia drug. A correlation in a significant positive manner between resistin with chemerin, TG, VLDL-C, and CK-MB was observed, while HDL-C showed significant negative correlation with resistin in the patients group. Chemerin also has a significant positive correlation with TC in. No conclusion in the abstract the Levels of chemerin and resistin were observed to be significantly higher in patients compared to healthy controls, but the increase in chemerin and resistin was associated with changes in other parameters studied in patients. Therefore, the significant increase in chemerin and resistin may be used as new factors in monitoring or to indicate the extent of MI patients.
References
- Ferreira JC, Mochly-Rosen D (2012). Nitroglycerin use in myocardial infarction patients. Circ J.76(1):15-21.
- Hegazy A (2018). Clinical anatomy of thorax for medical students and doctors. LAP, Lambert Academic Publishing.
- Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A(2010). Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol.Feb;35(2):72-115.
- Kushner FG, Bates ER(2013). St-segment elevation myocardial infarction. In Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease, Fourth Edition, Jan 1 (pp. 178-213).WB Saunders.
- Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012). Third universal definition of myocardial infarction. circulation, 126(16), 2020-2035.
- Kushner, F. G., Ascheim, D. D., de Lemos, J. A., & Ettinger, S. M. (2013). ACCF/AHA Guideline. Circulation, 127, e362-e425.
- Steppan, C. M., & Lazar, M. A. (2004). The current biology of resistin. Journal of internal medicine, 255(4), 439-447.
- Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., ... & Lazar, M. A. (2001). The hormone resistin links obesity to diabetes. Nature, 409(6818), 307-312.
- Verma, S., Li, S. H., Wang, C. H., Fedak, P. W., Li, R. K., Weisel, R. D., & Mickle, D. A. (2003). Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation, 108(6), 736-740.
- Calabro, P., Samudio, I., Willerson, J. T., & Yeh, E. T. (2004). Resistin promotes smooth muscle cell proliferation through activation of extracellular signal–regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation, 110(21), 3335-3340.
- Burnett, M. S., Lee, C. W., Kinnaird, T. D., Stabile, E., Durrani, S., Dullum, M. K., ... & Epstein, S. E. (2005). The potential role of resistin in atherogenesis. Atherosclerosis, 182(2), 241-248.
- Ohmori, R., Momiyama, Y., Kato, R., Taniguchi, H., Ogura, M., Ayaori, M., ... & Ohsuzu, F. (2005). Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. Journal of the American College of Cardiology, 46(2), 379-380.
- Pischon, T., Bamberger, C. M., Kratzsch, J., Zyriax, B. C., Algenstaedt, P., Boeing, H., & Windler, E. (2005). Association of plasma resistin levels with coronary heart disease in women. Obesity research, 13(10), 1764-1771.
- Ferland, D. J., & Watts, S. W. (2015). Chemerin: a comprehensive review elucidating the need for cardiovascular research. Pharmacological research, 99, 351-361.
- Rodríguez-Penas, D., Feijóo-Bandín, S., García-Rúa, V., Mosquera-Leal, A., Durán, D., Varela, A., ... & Lago, F. (2015). The adipokine chemerin induces apoptosis in cardiomyocytes. Cellular Physiology and Biochemistry, 37(1), 176-192.
- Zhang, O., Ji, Q., Lin, Y., Wang, Z., Huang, Y., Lu, W., ... & Zhou, Y. J. (2015). Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure. Clinica chimica acta, 448, 27-32.
- Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., ... & Segal, D. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148(10), 4687-4694.
- Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., ... & Blüher, M. (2012). Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism, 61(5), 706-714.
- Kostopoulos, C. G., Spiroglou, S. G., Varakis, J. N., Apostolakis, E., & Papadaki, H. H. (2014). Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?. BMC Cardiovascular Disorders, 14, 1-9.
- AL Azzawy, RQ. (2018). Physiological, chemical and hormonal changes for a number of heart diseases in Kirkuk Governorate . master Thesis، college of Education for Women University of Tikrit.
- Kumar, N., Kumar, S., Kumar, A., Shakoor, T., & Rizwan, A. (2019). Lipid profile of patients with acute myocardial infarction (AMI). Cureus, 11(3).
- Velho, G.; Ragot, S.; El Boustany, R.; Saulnier, P.; Fraty, M.; Mohammedi, K., ... & Roussel, R. (2018). Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovascular diabetology, 17(1), 110.
- Kopecky, C.; Ebtehaj, S.; Genser, B.; Drechsler, C.; Krane, V.; Antlanger, M. & Weichhart, T. (2017). HDL cholesterol efflux does not predict cardiovascular risk in hemodialysis patients. Journal of the American Society of Nephrology, 28(3); 769-775.
- Chapman, MJ.; Ginsberg, HN.; Amarenco, P.; et al. (2011). Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J;32:1345– 61.
- Allwsh , TA.; Aziz,NM.(2015). Clinical study of copeptin in serum patiants of heart diseases. Department of Chemistry , College of Science , University of Mosul, Mosul , Iraq. ISSN:1813 – 1662.
- Saleem, M. M. (2012). Determination of Some Biochemical Marker Levels in Serum of Patients with Congestive Heart Failure, Angina Pectorisand Myocardial Infarction. Eng. &Tech. Journal, 30(6), 939-949.
- Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003). The prevalence and etiology of elevated aminotransferase levels in the United States. The American journal of gastroenterology, 98(5), 960-967.
- Khalil, OA.; Ramadan, KS.; Hamza, AH. and El-Toukhy, SE. (2013). Association of plasma protein C levels and coronary artery disease in men. Afr. J. Biotechnol. ,12(50):6986-6991.
- Zahid, Z.;Shad, M.; Sheikh, M. & Nawaz, H. (2018). Occupational Exposure to Industrial Pollution Elevates the Levels of Myocardial Enzymes: A Leading Cause of Cardiovascular Abnormalities in Industrial Workers. Pakistan Journal of Life & Social Sciences, 16(1).
- Bodor ,GS. (2016).Biochemical markers of myocardial damage. Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicin, 27: 95.
- Shamil, A. (2018). Evaluation of Some Biochemical Parameters in Serum of Patients Suffering from Acute Coronary Syndrome . Diploma thesis , Medical Laboratory Science. Tikrit University.
- Horjus, DJ. (2019). Creatine kinase and cardiovascular disease. British Journal of Clinical Pharmacology, 34: 1306–1311.
- Roffi, M.; Patrono, C.; Collet, JP.; Mueller, C.; Valgimigli, M.; Andreotti, F.; et al. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting 129 without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J;37:267–315.
- Amsterdam, EA.; Wenger, NK.; Brindis, RG.; Casey, DE Jr.; Ganiats, TG.; Holmes, DR Jr.; et al. (2014). AHA/ACC Guideline for the Management of Patients with Non STElevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139 –228.
- Dasgupta, A., and Wahed, A. (2013). Clinical chemistry, mimmunology and laboratory quality control: a comprehensive review for board preparation, certification and clinical practice. AcademicmPress.
- Chu, S., Ding, W., Li, K., Pang, Y., & Tang, C. (2008). Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circulation Journal, 72(8), 1249-1253.
- Ibrahim, A. E., EL-Yassin, H. D., & AL-Janabi, H. K. S. (2011). The impact of inflammation on Resistin, IL-6 and CRP in Acute Myocardial Infarction Patients. Journal of the Faculty of Medicine Baghdad, 53(2), 216-220.
- Wang, B., Kou, W., Ji, S., Shen, R., Ji, H., Zhuang, J., ... & Xu, Y. (2022). Prognostic value of plasma adipokine chemerin in patients with coronary artery disease. Frontiers in Cardiovascular Medicine, 9, 968349.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 CC BY 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
